HEADER TRANSFERASE 21-DEC-18 6NG0 TITLE CRYSTAL STRUCTURE OF HPK1 KINASE DOMAIN T165E,S171E PHOSPHOMIMETIC TITLE 2 MUTANT IN COMPLEX WITH SUNITINIB IN THE INACTIVE STATE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HEMATOPOIETIC PROGENITOR KINASE,MAPK/ERK KINASE KINASE COMPND 5 KINASE 1,MEKKK 1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K1, HPK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, 3D DOMAIN SWAP, INACTIVE STATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.JOHNSON,M.MCTIGUE,C.N.CRONIN REVDAT 5 13-MAR-24 6NG0 1 COMPND HETNAM REVDAT 4 26-JUN-19 6NG0 1 JRNL REVDAT 3 19-JUN-19 6NG0 1 JRNL REVDAT 2 08-MAY-19 6NG0 1 JRNL REVDAT 1 01-MAY-19 6NG0 0 JRNL AUTH E.JOHNSON,M.MCTIGUE,R.A.GALLEGO,T.W.JOHNSON,S.TIMOFEEVSKI, JRNL AUTH 2 M.MAESTRE,T.S.FISHER,R.KANIA,S.SAWASDIKOSOL,S.BURAKOFF, JRNL AUTH 3 C.N.CRONIN JRNL TITL MULTIPLE CONFORMATIONAL STATES OF THE HPK1 KINASE DOMAIN IN JRNL TITL 2 COMPLEX WITH SUNITINIB REVEAL THE STRUCTURAL CHANGES JRNL TITL 3 ACCOMPANYING HPK1 TRANS-REGULATION. JRNL REF J.BIOL.CHEM. V. 294 9029 2019 JRNL REFN ESSN 1083-351X JRNL PMID 31018963 JRNL DOI 10.1074/JBC.AC119.007466 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 42208 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 2160 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.55 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 845 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2200 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 806 REMARK 3 BIN R VALUE (WORKING SET) : 0.2198 REMARK 3 BIN FREE R VALUE : 0.2239 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.62 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 39 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4336 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.10790 REMARK 3 B22 (A**2) : -0.59080 REMARK 3 B33 (A**2) : 8.69870 REMARK 3 B12 (A**2) : -7.99280 REMARK 3 B13 (A**2) : 6.08210 REMARK 3 B23 (A**2) : -8.13660 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.185 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.156 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.186 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.158 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4486 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6076 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1535 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 787 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4486 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 578 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5354 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.76 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.71 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NG0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000236783. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 180 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43684 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.026 REMARK 200 RESOLUTION RANGE LOW (A) : 60.176 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.03600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.50100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 NL PROTEIN (15 MG/ML) PLUS 300 NL REMARK 280 RESERVOIR SOLUTION (0.1 M TRIS, PH 8.0, 17.5 % 1,6-HEXANEDIOL, REMARK 280 10 MM MAGNESIUM SULFATE, 24 MM BARIUM ACETATE), VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 286.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 VAL A 3 REMARK 465 VAL A 4 REMARK 465 ASP A 5 REMARK 465 GLY A 26 REMARK 465 THR A 27 REMARK 465 TYR A 28 REMARK 465 GLN A 161 REMARK 465 ILE A 162 REMARK 465 GLY A 163 REMARK 465 ALA A 164 REMARK 465 GLU A 165 REMARK 465 ILE A 303 REMARK 465 GLU A 304 REMARK 465 ASP A 305 REMARK 465 GLU A 306 REMARK 465 GLU A 307 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 VAL B 3 REMARK 465 VAL B 4 REMARK 465 ASP B 5 REMARK 465 PRO B 6 REMARK 465 GLY B 26 REMARK 465 THR B 27 REMARK 465 TYR B 28 REMARK 465 GLY B 29 REMARK 465 MET B 50 REMARK 465 GLU B 51 REMARK 465 PRO B 52 REMARK 465 ASP B 53 REMARK 465 PRO B 294 REMARK 465 GLY B 295 REMARK 465 LYS B 296 REMARK 465 GLY B 297 REMARK 465 PRO B 298 REMARK 465 SER B 299 REMARK 465 ILE B 300 REMARK 465 GLY B 301 REMARK 465 ASP B 302 REMARK 465 ILE B 303 REMARK 465 GLU B 304 REMARK 465 ASP B 305 REMARK 465 GLU B 306 REMARK 465 GLU B 307 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 53 CG OD1 OD2 REMARK 470 ILE A 158 CG1 CG2 CD1 REMARK 470 SER A 159 OG REMARK 470 LEU A 166 CG CD1 CD2 REMARK 470 ARG A 168 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 169 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 170 CG CD1 CD2 REMARK 470 GLU A 171 CG CD OE1 OE2 REMARK 470 PHE A 172 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 ASN A 293 CG OD1 ND2 REMARK 470 LYS A 296 CG CD CE NZ REMARK 470 ASP B 7 CG OD1 OD2 REMARK 470 ILE B 8 CG1 CG2 CD1 REMARK 470 ASN B 10 CG OD1 ND2 REMARK 470 ARG B 11 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 22 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 30 CG CD OE1 OE2 REMARK 470 LYS B 49 CG CD CE NZ REMARK 470 ASP B 54 CG OD1 OD2 REMARK 470 ASP B 55 CG OD1 OD2 REMARK 470 VAL B 56 CG1 CG2 REMARK 470 SER B 57 OG REMARK 470 LEU B 59 CG CD1 CD2 REMARK 470 GLN B 60 CG CD OE1 NE2 REMARK 470 LEU B 82 CG CD1 CD2 REMARK 470 TRP B 83 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 83 CZ3 CH2 REMARK 470 LEU B 84 CG CD1 CD2 REMARK 470 GLN B 85 CG CD OE1 NE2 REMARK 470 GLU B 165 CG CD OE1 OE2 REMARK 470 ARG B 168 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 169 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 171 CG CD OE1 OE2 REMARK 470 PHE B 172 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE B 173 CG1 CG2 CD1 REMARK 470 LYS B 292 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 108 141.39 -39.84 REMARK 500 ARG A 136 -8.02 77.74 REMARK 500 LYS A 240 -74.47 -106.43 REMARK 500 LEU A 255 38.73 -92.55 REMARK 500 ASP B 12 129.22 -39.20 REMARK 500 LEU B 20 -165.85 -122.51 REMARK 500 GLN B 85 -0.29 66.81 REMARK 500 ARG B 136 -7.21 68.34 REMARK 500 ASP B 137 44.79 -141.90 REMARK 500 LYS B 189 23.99 -146.59 REMARK 500 LEU B 255 44.11 -91.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B49 A 9000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B49 B 9000 DBREF 6NG0 A 1 307 UNP Q92918 M4K1_HUMAN 1 307 DBREF 6NG0 B 1 307 UNP Q92918 M4K1_HUMAN 1 307 SEQADV 6NG0 GLY A -1 UNP Q92918 EXPRESSION TAG SEQADV 6NG0 SER A 0 UNP Q92918 EXPRESSION TAG SEQADV 6NG0 GLU A 165 UNP Q92918 THR 165 ENGINEERED MUTATION SEQADV 6NG0 GLU A 171 UNP Q92918 SER 171 ENGINEERED MUTATION SEQADV 6NG0 GLY B -1 UNP Q92918 EXPRESSION TAG SEQADV 6NG0 SER B 0 UNP Q92918 EXPRESSION TAG SEQADV 6NG0 GLU B 165 UNP Q92918 THR 165 ENGINEERED MUTATION SEQADV 6NG0 GLU B 171 UNP Q92918 SER 171 ENGINEERED MUTATION SEQRES 1 A 309 GLY SER MET ASP VAL VAL ASP PRO ASP ILE PHE ASN ARG SEQRES 2 A 309 ASP PRO ARG ASP HIS TYR ASP LEU LEU GLN ARG LEU GLY SEQRES 3 A 309 GLY GLY THR TYR GLY GLU VAL PHE LYS ALA ARG ASP LYS SEQRES 4 A 309 VAL SER GLY ASP LEU VAL ALA LEU LYS MET VAL LYS MET SEQRES 5 A 309 GLU PRO ASP ASP ASP VAL SER THR LEU GLN LYS GLU ILE SEQRES 6 A 309 LEU ILE LEU LYS THR CYS ARG HIS ALA ASN ILE VAL ALA SEQRES 7 A 309 TYR HIS GLY SER TYR LEU TRP LEU GLN LYS LEU TRP ILE SEQRES 8 A 309 CYS MET GLU PHE CYS GLY ALA GLY SER LEU GLN ASP ILE SEQRES 9 A 309 TYR GLN VAL THR GLY SER LEU SER GLU LEU GLN ILE SER SEQRES 10 A 309 TYR VAL CYS ARG GLU VAL LEU GLN GLY LEU ALA TYR LEU SEQRES 11 A 309 HIS SER GLN LYS LYS ILE HIS ARG ASP ILE LYS GLY ALA SEQRES 12 A 309 ASN ILE LEU ILE ASN ASP ALA GLY GLU VAL ARG LEU ALA SEQRES 13 A 309 ASP PHE GLY ILE SER ALA GLN ILE GLY ALA GLU LEU ALA SEQRES 14 A 309 ARG ARG LEU GLU PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 15 A 309 PRO GLU VAL ALA ALA VAL ALA LEU LYS GLY GLY TYR ASN SEQRES 16 A 309 GLU LEU CYS ASP ILE TRP SER LEU GLY ILE THR ALA ILE SEQRES 17 A 309 GLU LEU ALA GLU LEU GLN PRO PRO LEU PHE ASP VAL HIS SEQRES 18 A 309 PRO LEU ARG VAL LEU PHE LEU MET THR LYS SER GLY TYR SEQRES 19 A 309 GLN PRO PRO ARG LEU LYS GLU LYS GLY LYS TRP SER ALA SEQRES 20 A 309 ALA PHE HIS ASN PHE ILE LYS VAL THR LEU THR LYS SER SEQRES 21 A 309 PRO LYS LYS ARG PRO SER ALA THR LYS MET LEU SER HIS SEQRES 22 A 309 GLN LEU VAL SER GLN PRO GLY LEU ASN ARG GLY LEU ILE SEQRES 23 A 309 LEU ASP LEU LEU ASP LYS LEU LYS ASN PRO GLY LYS GLY SEQRES 24 A 309 PRO SER ILE GLY ASP ILE GLU ASP GLU GLU SEQRES 1 B 309 GLY SER MET ASP VAL VAL ASP PRO ASP ILE PHE ASN ARG SEQRES 2 B 309 ASP PRO ARG ASP HIS TYR ASP LEU LEU GLN ARG LEU GLY SEQRES 3 B 309 GLY GLY THR TYR GLY GLU VAL PHE LYS ALA ARG ASP LYS SEQRES 4 B 309 VAL SER GLY ASP LEU VAL ALA LEU LYS MET VAL LYS MET SEQRES 5 B 309 GLU PRO ASP ASP ASP VAL SER THR LEU GLN LYS GLU ILE SEQRES 6 B 309 LEU ILE LEU LYS THR CYS ARG HIS ALA ASN ILE VAL ALA SEQRES 7 B 309 TYR HIS GLY SER TYR LEU TRP LEU GLN LYS LEU TRP ILE SEQRES 8 B 309 CYS MET GLU PHE CYS GLY ALA GLY SER LEU GLN ASP ILE SEQRES 9 B 309 TYR GLN VAL THR GLY SER LEU SER GLU LEU GLN ILE SER SEQRES 10 B 309 TYR VAL CYS ARG GLU VAL LEU GLN GLY LEU ALA TYR LEU SEQRES 11 B 309 HIS SER GLN LYS LYS ILE HIS ARG ASP ILE LYS GLY ALA SEQRES 12 B 309 ASN ILE LEU ILE ASN ASP ALA GLY GLU VAL ARG LEU ALA SEQRES 13 B 309 ASP PHE GLY ILE SER ALA GLN ILE GLY ALA GLU LEU ALA SEQRES 14 B 309 ARG ARG LEU GLU PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 15 B 309 PRO GLU VAL ALA ALA VAL ALA LEU LYS GLY GLY TYR ASN SEQRES 16 B 309 GLU LEU CYS ASP ILE TRP SER LEU GLY ILE THR ALA ILE SEQRES 17 B 309 GLU LEU ALA GLU LEU GLN PRO PRO LEU PHE ASP VAL HIS SEQRES 18 B 309 PRO LEU ARG VAL LEU PHE LEU MET THR LYS SER GLY TYR SEQRES 19 B 309 GLN PRO PRO ARG LEU LYS GLU LYS GLY LYS TRP SER ALA SEQRES 20 B 309 ALA PHE HIS ASN PHE ILE LYS VAL THR LEU THR LYS SER SEQRES 21 B 309 PRO LYS LYS ARG PRO SER ALA THR LYS MET LEU SER HIS SEQRES 22 B 309 GLN LEU VAL SER GLN PRO GLY LEU ASN ARG GLY LEU ILE SEQRES 23 B 309 LEU ASP LEU LEU ASP LYS LEU LYS ASN PRO GLY LYS GLY SEQRES 24 B 309 PRO SER ILE GLY ASP ILE GLU ASP GLU GLU HET B49 A9000 29 HET B49 B9000 29 HETNAM B49 N-[2-(DIETHYLAMINO)ETHYL]-5-[(Z)-(5-FLUORO-2-OXO-1,2- HETNAM 2 B49 DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H- HETNAM 3 B49 PYRROLE-3-CARBO XAMIDE HETSYN B49 SUNITINIB FORMUL 3 B49 2(C22 H27 F N4 O2) FORMUL 5 HOH *320(H2 O) HELIX 1 AA1 ASP A 12 ASP A 15 5 4 HELIX 2 AA2 ASP A 55 THR A 68 1 14 HELIX 3 AA3 SER A 98 GLY A 107 1 10 HELIX 4 AA4 SER A 110 GLN A 131 1 22 HELIX 5 AA5 LYS A 139 ALA A 141 5 3 HELIX 6 AA6 ARG A 168 ILE A 173 1 6 HELIX 7 AA7 ALA A 180 GLY A 190 1 11 HELIX 8 AA8 LEU A 195 LEU A 211 1 17 HELIX 9 AA9 HIS A 219 LYS A 229 1 11 HELIX 10 AB1 SER A 244 LEU A 255 1 12 HELIX 11 AB2 SER A 264 LEU A 269 1 6 HELIX 12 AB3 HIS A 271 GLN A 276 1 6 HELIX 13 AB4 ARG A 281 ASN A 293 1 13 HELIX 14 AB5 ASP B 12 ASP B 15 5 4 HELIX 15 AB6 ASP B 55 THR B 68 1 14 HELIX 16 AB7 SER B 98 GLY B 107 1 10 HELIX 17 AB8 SER B 110 GLN B 131 1 22 HELIX 18 AB9 LYS B 139 ALA B 141 5 3 HELIX 19 AC1 ILE B 158 PHE B 172 1 15 HELIX 20 AC2 ALA B 180 GLY B 190 1 11 HELIX 21 AC3 LEU B 195 LEU B 211 1 17 HELIX 22 AC4 HIS B 219 THR B 228 1 10 HELIX 23 AC5 GLU B 239 TRP B 243 5 5 HELIX 24 AC6 SER B 244 LEU B 255 1 12 HELIX 25 AC7 SER B 264 LEU B 269 1 6 HELIX 26 AC8 HIS B 271 GLN B 276 1 6 HELIX 27 AC9 ARG B 281 ASN B 293 1 13 SHEET 1 AA1 6 ILE A 8 PHE A 9 0 SHEET 2 AA1 6 TYR A 77 LEU A 82 1 O SER A 80 N PHE A 9 SHEET 3 AA1 6 LYS A 86 GLU A 92 -1 O CYS A 90 N GLY A 79 SHEET 4 AA1 6 LEU A 42 LYS A 49 -1 N LYS A 46 O ILE A 89 SHEET 5 AA1 6 GLU A 30 ASP A 36 -1 N GLU A 30 O MET A 47 SHEET 6 AA1 6 TYR A 17 GLY A 24 -1 N GLY A 24 O VAL A 31 SHEET 1 AA2 2 ILE A 143 ILE A 145 0 SHEET 2 AA2 2 VAL A 151 LEU A 153 -1 O ARG A 152 N LEU A 144 SHEET 1 AA3 6 ILE B 8 PHE B 9 0 SHEET 2 AA3 6 TYR B 77 TRP B 83 1 O LEU B 82 N PHE B 9 SHEET 3 AA3 6 LYS B 86 GLU B 92 -1 O CYS B 90 N GLY B 79 SHEET 4 AA3 6 LEU B 42 VAL B 48 -1 N VAL B 48 O LEU B 87 SHEET 5 AA3 6 VAL B 31 ASP B 36 -1 N PHE B 32 O LEU B 45 SHEET 6 AA3 6 TYR B 17 GLY B 24 -1 N LEU B 23 O VAL B 31 SHEET 1 AA4 2 ILE B 143 ILE B 145 0 SHEET 2 AA4 2 VAL B 151 LEU B 153 -1 O ARG B 152 N LEU B 144 SITE 1 AC1 12 LEU A 23 ALA A 44 MET A 91 GLU A 92 SITE 2 AC1 12 PHE A 93 CYS A 94 GLY A 95 GLY A 97 SITE 3 AC1 12 ASP A 101 LEU A 144 ALA A 154 ASP A 155 SITE 1 AC2 13 LEU B 23 ALA B 44 MET B 91 GLU B 92 SITE 2 AC2 13 PHE B 93 CYS B 94 GLY B 95 GLY B 97 SITE 3 AC2 13 ASP B 101 LEU B 144 ASP B 155 PHE B 156 SITE 4 AC2 13 HOH B9139 CRYST1 55.810 58.920 60.930 82.44 82.31 64.34 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017918 -0.008608 -0.001716 0.00000 SCALE2 0.000000 0.018829 -0.001557 0.00000 SCALE3 0.000000 0.000000 0.016618 0.00000